New hope for tough pancreatic cancer cases: immune drug added to chemo
NCT ID NCT05630183
Summary
This study is testing whether adding an immunotherapy drug called botensilimab to standard chemotherapy works better than chemotherapy alone for people with metastatic pancreatic cancer that has worsened after initial treatment. About 81 participants will be randomly assigned to receive either the combination or just chemotherapy. The main goal is to see if the combination helps keep the cancer from growing for a longer period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atlantic Health Systems, Morristown
Morristown, New Jersey, 07960, United States
-
Baylor Charles A. Sammons Cancer Center
Dallas, Texas, 75247, United States
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Cancer Care Centers of Brevard
Palm Bay, Florida, 32909, United States
-
Comprehensive Cancer Centers of Nevada - Summerlin Medical Center II*
Las Vegas, Nevada, 89144, United States
-
Florida Cancer Specialist North
St. Petersburg, Florida, 22705, United States
-
Florida Cancer Specialist South
Fort Myers, Florida, 33901, United States
-
HonorHealth
Scottsdale, Arizona, 85258, United States
-
Icahn School of Medicine at Mount Sinai Tisch Cancer Institute
New York, New York, 10128, United States
-
Illinois Cancer Specialists
Arlington Heights, Illinois, 60005, United States
-
John Theurer Cancer Center at Hackensack
Hackensack, New Jersey, 07601, United States
-
Lifespan
Providence, Rhode Island, 02903, United States
-
Maryland Oncology Hematology
Columbia, Maryland, 21044, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Medical Oncology Hematology Consultants (MOHC) - Helen F. Graham Cancer Center
Newark, Delaware, 19713, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Minnesota Oncology
Minneapolis, Minnesota, 55404, United States
-
Nebraska Medicine-Nebraska Medical Center
Omaha, Nebraska, 68198, United States
-
Northeast Texas Cancer & Research Institute
Tyler, Texas, 75702, United States
-
Oncology Hematology Care - Eastgate
Cincinnati, Ohio, 45245, United States
-
Overlook Medical Center
Summit, New Jersey, 07901, United States
-
Rogel Cancer Center, University of Michigan Medicine
Ann Arbor, Michigan, 48109, United States
-
Sarah Cannon Research Institute at Tennessee Oncology
Cincinnati, Ohio, 45245, United States
-
Sarah Cannon Research Institute at Tennessee Oncology
Nashville, Tennessee, 37203, United States
-
Shenandoah Oncology
Winchester, Virginia, 22601, United States
-
Swedish Cancer Institute
Seattle, Washington, 98104, United States
-
Texas Oncology
Carrollton, Texas, 75010, United States
-
The Center for Cancer & Blood Disorders: Fort Worth
Fort Worth, Texas, 76104, United States
-
TxO - Denison Cancer Center
Denison, Texas, 75020, United States
-
UCLA Health - Santa Monica Cancer Care
Santa Monica, California, 90404, United States
-
USC Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
-
USC Norris Oncology
Newport Beach, California, 92663, United States
-
Virginia Cancer Specialists
Fairfax, Virginia, 22031, United States
-
Virginia Oncology Associates - Brock Cancer Center
Norfolk, Virginia, 23502, United States
-
Weill Cornell Medicine Sandra and Edward Meyer Cancer Center
New York, New York, 10065, United States
-
Weill Cornell Medicine-New York Presbyterian Hospital
New York, New York, 10021, United States
Conditions
Explore the condition pages connected to this study.